A detailed history of Wr Wealth Planners, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Wr Wealth Planners, LLC holds 2,800 shares of HRTX stock, worth $4,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,800
Previous 2,800 -0.0%
Holding current value
$4,900
Previous $9,000 44.44%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$2.32 - $3.86 $1,160 - $1,930
-500 Reduced 15.15%
2,800 $9,000
Q1 2024

Jul 31, 2024

BUY
$1.71 - $3.06 $5,643 - $10,098
3,300 New
3,300 $9,000
Q2 2023

Aug 01, 2024

BUY
$1.11 - $2.88 $1,110 - $2,880
1,000 Added 35.71%
3,800 $4.41 Million
Q1 2023

Aug 01, 2024

BUY
$1.51 - $3.25 $1,510 - $3,250
1,000 Added 35.71%
3,800 $5.74 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $208M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Wr Wealth Planners, LLC Portfolio

Follow Wr Wealth Planners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wr Wealth Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wr Wealth Planners, LLC with notifications on news.